MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma

Prognostic Role of Chicken Ovalbumin Upstream Promoter Transcription Factor II in Isocitrate Dehydrogenase-Mutant Glioma with 1p19q Co-Deletion

(2019) Yi Chai et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Reduced expression of DNA repair genes and chemosensitivity in 1p19q codeleted lower-grade gliomas

(2018) Lei Tang et al.   JOURNAL OF NEURO-ONCOLOGY

Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase–mutant glioma

(2018) Michael Karsy et al.   JOURNAL OF NEUROSURGERY

Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma

(2018) Ae Kyung Park et al.   NEURO-ONCOLOGY

Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma

(2018) Er Nie et al.   ONCOGENE

LAPTM4B-35 is a novel prognostic factor for glioblastoma

(2017) Xiaoshud Dong et al.   JOURNAL OF NEURO-ONCOLOGY

Regulation of DNA Alkylation Damage Repair: Lessons and Therapeutic Opportunities

(2017) Jennifer M. Soll et al.   TRENDS IN BIOCHEMICAL SCIENCES

Functional Properties of the Mitochondrial Carrier System

(2017) Eric B. Taylor   TRENDS IN CELL BIOLOGY

MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer

(2016) Xiaoli Li et al.   BMC CANCER

Glioblastoma: pathology, molecular mechanisms and markers

(2015) Kenneth Aldape et al.   ACTA NEUROPATHOLOGICA

Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance

(2015) Malin Wickström et al.   Nature Communications

Treatment of Elderly Patients With Glioblastoma

(2015) Oren J. Zarnett et al.   JAMA Neurology

MGMT testing—the challenges for biomarker-based glioma treatment

(2014) Wolfgang Wick et al.   Nature Reviews Neurology

Identification and Functional Expression of the Mitochondrial Pyruvate Carrier

(2012) S. Herzig et al.   SCIENCE

A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans

(2012) D. K. Bricker et al.   SCIENCE

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

O6-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation

(2011) Simone Kreth et al.   PLoS One

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

(2009) Michael Weller et al.   Nature Reviews Neurology

Transcript-Specific Expression Profiles Derived from Sequence-Based Analysis of Standard Microarrays

(2009) Anton G. Moll et al.   PLoS One

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE

The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation

(2008) Ralph J. DeBerardinis et al.   Cell Metabolism

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

(2008) Roger McLendon et al.   NATURE

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE